Outlook Therapeutics (41O) Q2 2026 Earnings Report
DE:41O Q2 2026 EPS Results
- Actual EPS
- -EUR 0.14
- Consensus EPS
- -EUR 0.11
- Beat/Miss
- Missed by -EUR 0.03
- One Year Ago EPS
- -EUR 0.36
DE:41O Q2 2026 Revenue Results
- Actual Revenue
- EUR 113.73K
- Expected Revenue
- EUR 3.92M
- Beat/Miss
- Missed by -EUR 3.80M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 05/15/2026
- Time
- After Close
- Conference Call
- Friday, May 15, 2026
DE:41O Upcoming Earnings
Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:41O Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 18, 2026 | 2026 (Q4) | -0.06- | -0.05 | ― | ― |
| Aug 14, 2026 | 2026 (Q3) | -0.07-0.08 | -0.39 | 79.55% (+0.31) | |
| May 15, 2026 | 2026 (Q2) | -0.11-0.14 | -0.36 | 60.00% (+0.21) | |
| Feb 17, 2026 | 2026 (Q1) | -0.20-0.20 | -0.79 | 75.28% (+0.60) | |
| Dec 19, 2025 | 2025 (Q4) | -0.23-0.05 | -0.79 | 93.18% (+0.73) | |
| Aug 14, 2025 | 2025 (Q3) | -0.31-0.39 | -0.74 | 46.99% (+0.35) | |
| May 15, 2025 | 2025 (Q2) | -0.48-0.36 | -1.38 | 74.19% (+1.03) | |
| Feb 14, 2025 | 2025 (Q1) | -0.68-0.79 | -0.71 | -11.25% (-0.08) | |
| Dec 27, 2024 | 2024 (Q4) | -0.72-0.79 | -0.89 | 12.00% (+0.11) | |
| Aug 14, 2024 | 2024 (Q3) | -0.92-0.74 | -1.43 | 48.13% (+0.69) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed